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ABSTRACT 
No comprehensive review of Bayesian networks (BNs) in healthcare has been published in the past, making 
it difficult to organize the research contributions in the present and identify challenges and neglected areas 
that need to be addressed in the future. This unique and novel scoping review of BNs in healthcare provides 
an analytical framework for comprehensively characterizing the domain and its current state. The review 
shows that: (1) BNs in healthcare are not used to their full potential; (2) a generic BN development process 
is lacking; (3) limitations exist in the way BNs in healthcare are presented in the literature, which impacts 
understanding, consensus towards systematic methodologies, practice and adoption of BNs; and (4) a gap 
exists between having an accurate BN and a useful BN that impacts clinical practice. This review empowers 
researchers and clinicians with an analytical framework and findings that will enable understanding of the 
need to address the problems of restricted aims of BNs, ad hoc BN development methods, and the lack of 
BN adoption in practice. To map the way forward, the paper proposes future research directions and makes 
recommendations regarding BN development methods and adoption in practice.  
CCS CONCEPTS 
• Mathematics of computing • Probability and statistics • Probabilistic inference problems • Bayesian 
computation 
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1 Introduction 
Bayesian Networks (BNs), also described as causal probabilistic models or belief networks, are directed 
acyclic graphical (DAG) models (Pearl 1988). Early attempts to use Bayesian analysis for medical problems 
were generally considered unsuccessful due to the necessary Bayesian inference being computationally 
intractable (Cooper 1990). Development of efficient BN inference propagation algorithms (Pearl 1988), 
(Heckerman 1995) and advances in computational power since, have made it possible to develop BNs capable 
of addressing real-world decision support problems. This led to renewed research interest which identified 
many thousands of publications describing BN solutions in the context of healthcare.  
The immense volume of published material demonstrates an enormous and rapidly increasing appetite for 
BNs as a reasoning tool to support healthcare delivery. With such significant research interest, it is important 
to properly organize and summarize the range of research contributions and enable identification of research 
gaps and future research directions. However, apart from a small number of micro-reviews about BNs for 
specific medical conditions (Bielza and Larranaga 2014) and one epidemiology-focused review on DAGs 
that is yet to be peer reviewed (Tennant et al. 2019), the domain lacks any form of systematic or scoping 
review. Additionally, evidence for their adoption in practice remains extremely limited. There is a significant 
gap between developing a claimed accurate model and demonstrating its clinical usefulness and actual impact 
on healthcare decision-making (Wyatt and Altman 1995; Blackmore 2005; Reilly and Evans 2006; Moons 
et al. 2009; Adams and Leveson 2012).  
This work presents a scoping review that examines and evaluates BNs in healthcare with specific regard to 
identifying the: (1) targeted decision support, (2) modelling approach, and (3) usefulness in practice. We 
believe that combined, these provide a global assessment of the research domain. To the best of our 
knowledge, this is the first scoping review on BNs in healthcare.  
The rest of this paper is organized as follows: Section 2 presents necessary background material related to 
BNs. Section 3 provides the motivation for undertaking this scoping review. The methodology followed and 
the obtained results are described in Sections 4 and 5, respectively. A list with all the major findings and a 
detailed discussion on the findings as well as the strength and limitation of this review are described in 
Sections 6 and 7, respectively. Section 8 offers a list of recommendations for the authors, while Section 9 
shows future research directions. Finally, a summary is provided in Section 10. 
2 Background 
In order to ground our objectives for this review it is necessary that we review and describe background 
material regarding: (1) the fundamentals of BNs, (2) the reasoning process in BNs, and (3) the significance 
of BNs. Readers familiar with some or all of the described preliminaries may select to skip these subsections.  
2.1 Bayesian fundamentals  
In late 1750, the English Mathematician and Reverend Thomas Bayes developed the now-famous Bayes’ 
theorem (Bayes, 1763). His study focused on how prior belief can be updated based on new evidence; a 
process now known as Bayesian inference, or Bayesian reasoning. Initial belief in the likelihood of a 
particular event or outcome are described as prior probabilities (for a hypothesis H we write this as P(H)); 
while updated beliefs in the light of new evidence E are posterior probabilities (written P(H|E) representing 
the conditional probability of H given E). This initial and updated belief process is common to everyday life. 
For example, when clinicians perform differential diagnosis in circumstances where multiple diseases present 
with similar symptoms. As new evidence from diagnostic tests and clinical examination of the patient become 
available, clinicians update their belief on what they consider to be the illness causing the patient’s poor 
health. 
Bayes’ theorem is a simple equation for calculating the posterior probability of a hypothesis H in terms of 
the prior probability, and the probability of the evidence conditional on H and its negation not H: 
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𝑃(𝐻|𝐸) = 𝑃(𝐸|𝐻)𝑃(𝐻)𝑃(𝐸|𝐻)𝑃(𝐻) + 𝑃(𝐸|𝑛𝑜𝑡	𝐻)𝑃(𝑛𝑜𝑡	𝐻) 
BNs are based on Bayes’ theorem and use a graphical approach for compact representation of multivariate 
probability distributions and efficient reasoning under uncertainty (Pearl, 1993). At its basic level, a BN is a 
directed acyclic graph with qualitative and quantitative parts (Pearl, 1993). The qualitative part is the BN 
structure comprised of nodes representing random variables (discrete or continuous) and directed arcs 
representing causal or influential relationships.  If a directed arc connects variables A and B, such as A→B, 
then A is called parent node or ancestor of B and B is a child node or a successor of A. The qualitative part is 
the BN parameters comprised of a set of conditional probability functions associated with each node – 
captured by a Node Probability Table (NPT) - to represent the conditional probability distribution of each 
node in the BN given its parents. 
Both BN structure and parameters can be prepared using: (a) automated learning from data if sufficient data 
are available (Dranca et al. 2018); (b) a manual “by-hand” approach using knowledge elicitation methods to 
capture domain expert knowledge and extracting the necessary information from literature (Philipp, Beyerer, 
and Fischer 2017); or, (c) through a combination of both (Flores et al. 2011). 
2.2 Reasoning process 
As values for all NPTs are provided the BN becomes fully parameterized (Figure 1a) such that it can be used 
in a variety of probabilistic reasoning processes (through applying Bayes theorem). There are three ways of 
reasoning with BNs: (i) observational reasoning that is reasoning from evidence; (ii) interventional 
reasoning; and (iii) counterfactual reasoning. 
Reasoning from evidence describes a joint distribution over possible observed events (Woodward 2003). 
Evidence represents the real world, what happened. Once evidence is observed into the BN, the probabilities 
of remaining unobserved variables can be updated. There are two approaches to reasoning from evidence: 
1. Causal reasoning: where the reasoning process follows the direction of the arc. For example: knowing 
that the patient is a smoker increases the probability of lung cancer from 6.4% (Figure 1a) to 10% (Figure 
1b), which in turn increases the probability of a positive X-ray result from 15.4% to 18.5%.  
2. Diagnostic reasoning: where the reasoning process is counter to the direction of the arc. For example: 
knowing that the patient’s X-ray is positive increases the probability of lung cancer (Figure 1c).  
 
 
 
 
a) 
	
 
 
 
 
b) 	
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c) 	
Figure 1: (a) A three-node BN example with Node Probability Tables shown, (b) A BN example, where causal 
reasoning is performed, (c) A BN example, where diagnostic reasoning is performed. 
BNs can also be used to answer hypothetical questions such as what will happen if an intervention is made. 
Interventional reasoning can only be performed when relationships among the variables are causal because 
an intervention is an exogenous action that fixes the state of the variable we have intervened upon, thus, 
making it independent of its causes (Pearl 1993; Pearl 2009; Shpitser and Pearl 2008). Contrary to reasoning 
about evidence, interventional reasoning does not allow diagnostic reasoning from the intervened variable 
(Hagmayer et al. 2007). For instance, when we observe a high body temperature on the thermometer, we can 
argue that we have a fever. However, if we arbitrarily start rubbing the thermometer to reach a specific 
temperature, we can no longer argue that we have a fever. According to Pearl (Pearl 2009), an externally 
imposed intervention is presented using the do operator. The process of making the intervened variable 
independent of its causes by removing all the edges pointing towards that variable is known as graph surgery. 
BNs can also be used to answer counterfactual questions such as what would have happened if events other 
than those observed had occured. Considering contrary-to-facts scenarios means imagining alternatives to 
reality. Although sometimes claimed otherwise (Dawid 2000), counterfactual reasoning is a natural reasoning 
process and is believed to be an ability unique to the human mind (Sloman 2013). In BNs, counterfactual 
reasoning combines both evidence and interventions. Using the process of twin-networks proposed by Pearl 
(Pearl 2009), the actual world is modelled based on evidence while the hypothetical counterfactual world is 
altered using interventions. In a twin network both networks have identical structures except for the arrows 
towards the variable that we intervene upon, which are missing in the hypothetical world. The posterior 
probabilities of the variables, which remain the same in both worlds, are called background variables, and 
are shared between the two networks. The main difference between counterfactuals and interventions is that 
for the former we know the values that some or all the variables had in the actual world. By contrast, when 
we intervene, we are unaware of the values of the predecessor variables in the network. 
 
2.3 Significance in healthcare 
Clinical decision making is a complex evolving process where evidence is gathered and diagnostic and 
treatment decisions are made (Tiffen, Corbridge, and Slimmer 2014). Through consideration of signs, 
symptoms, a patient’s history and any test results, clinicians try to resolve two main questions: ‘What is the 
problem?’ and ‘How can we solve it?’. Symptoms, diagnostic tests, diseases, treatment options, our complex 
human physiology and increased uncertainty can make clinical decision-making challenging. While 
clinicians can be good decision-makers, it can be difficult to combine all available evidence and accurately 
reason under conditions of such uncertainty (Bornstein and Emler 2001). 
Many clinical decision support systems (CDSS) have been developed to support clinicians in their decision-
making role (Druzdzel and Flynn 2002; Beattie and Nelson 2006; Patel et al. 2009; Adams and Leveson 
2012; Shortliffe and Cimino 2013). These can range from simple scoring systems to complicated multivariate 
regression models, neural networks, decision trees and graphical probabilistic models like BNs. BNs are 
being recognized as powerful tools for risk analysis and decision support for real-world problems and have 
become a popular CDSS model for healthcare application (Lucas 2001; Lucas, van der Gaag, and Abu-Hanna 
2004). Their popularity in healthcare results from their ability to: (i) model complex problems with causal 
dependencies where a significant degree of uncertainty is involved; (ii) combine different sources of 
	 5	
information such as data and experts’ judgement; (iii) have an interpretable graphical structure; and, (iv) 
model  interventions and reason both diagnostically and prognostically. 
3 Motivation 
The following conclusions were formulated from our preliminary review of BNs in healthcare (Kyrimi et al. 
2020):  
1. The body of literature on BNs in healthcare is large and rapidly increasing, indicating a significant 
research interest. 
2. The high volume of published works and lack of attempts to systematically review the domain are 
significant motivating factors for undertaking a systematic or scoping review to summarize the literature 
and highlight research gaps and future directions. 
3. The process of developing a BN is rarely described clearly in the literature to the point of being 
repeatable. 
4. Despite the obvious and widely accepted benefits of BNs and the enormous number of publications, 
there has been negligible clinical adoption of the BNs described in published articles. 
These conclusions provide a strong case to support conducting a larger scale review to identify causes for 
some of the highlighted issues and the proposal of a way forward towards their resolution. Indeed, the lack 
of such systematic or scoping reviews is likely to have led to duplication of effort and repetition of 
methodological mistakes, while at the same time allowed important research gaps to remain hidden. 
4 Methodology 
4.1 Literature search 
A comprehensive search of the major health and health informatics literature databases including PubMed, 
MedLine, ScienceDirect, Scopus, DOAJ and Elsevier was performed using a selection of keywords arranged 
in the following general search query:  
“(((Bayes OR Bayesian) AND network) OR (probabilistic AND graphical AND model)) AND (medical 
OR clinical)” 
Terms such as Bayesian networks or graphical probabilistic models were used here because they are widely 
observed in the targeted literature. Different ways for explaining the medical condition do occur, in that in 
some papers the exact condition is mentioned while in others broader terms such as medical or clinical 
application, medical or clinical condition, or medical or clinical setting are used. Our scoping review settled 
on the broader terms medical or clinical as they were found in a wider collection of papers. Searching for 
specific medical conditions would have been impractical as there are many thousands of distinct known 
conditions. 
Due to the high number of articles returned, further scrutiny was applied to narrow the collection to the most 
relevant articles for this study. This was achieved by assessing whether the described keywords were present 
in the abstract. Additional screening was conducted to exclude papers published outside the period 2012-
2018, those that were not published in English, or those whose primary content was not healthcare related. 
The remaining eligible papers were those possessing all the following identified characteristics. They: 
1. Describe a genuine BN model or BN modeling process or BN adoption process. 
2. Are targeted clearly at a medical condition or application. 
3. Are intended to support clinicians or patients in decision making or prediction  
4.2 Analytical framework for characterizing BNs in healthcare 
Figure 2 presents the analytical framework that has been developed in this work for use in characterizing the 
domain of BNs in healthcare. This framework also guides the review and analysis of the body of literature in 
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this study. In alignment with this framework, our review plan identified six primary objectives shown in 
Figure 2 that cover important aspects critical to harnessing BNs in healthcare. The focus of the results 
reported in this paper are limited to the following three of these objectives (leaving the remaining objectives 
to more focused investigations that will be presented in later papers): 
1. Objective 1 – Decision support: This objective involves investigating published BN models focusing on 
the identification of: (1) the reasoning processes which have been defined in Section 2; and (2) the type 
of decision support associated with the reasoning process, which influences and is influenced by the 
temporal aspect of the medical problem. 
2. Objective 2 – Modelling approach: BN development was identified and broken into two parts, each 
determined by: (1) the BN structure (variables and arcs), and (2) the conditional probabilities for each 
variable (parameters). The source for variables, arcs and parameters was identified and recorded. 
Additionally, we explored whether the paper provided a repeatable overall BN development process 
along with a clear description of the structure and parameter elicitation or learning process. Finally, the 
distribution of BN software tools used by authors, where identified, was captured.  
3. Objective 3 – Model usefulness: The potential usefulness of published BNs to clinical practice was 
examined. Many researchers have investigated the gap between developing an accurate model and 
having a useful model that has or can have an actual impact on the clinical decision-making process 
(Reilly and Evans 2006; Moons et al. 2009; Altman et al. 2009; Adams and Leveson 2012). Based on 
existing literature (Wyatt and Altman 1995; Blackmore 2005; Toll et al. 2008), the properties presented 
in Table 1 are considered necessary and should be present to ensure a useful model.   
Table 1: Review framework for model usefulness.   Properties	 Description	
Benefit The BN addresses a clinical question of enough importance that has a margin of 
improvement to justify time by practitioners  
Credibility The BN has a clear logic and appears to describe what it intends to describe 
Accuracy The BN has an acceptable predictive performance (internal validation) 
Generalizability The BN has an acceptable accuracy in datasets other than the original training dataset 
(temporal and/or external validation) 
Usability There is an interface adjusted to the user’s needs 
Impact The model must have potential to change patient care 	
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Figure 2: Framework for characterizing the domain of Bayesian networks in healthcare. 
Each objective identified in Figure 2 captures a unique attribute from the literature on BNs in healthcare. The 
first three objectives when combined provide a global assessment of the BNs in healthcare domain. As shown 
in Figure 2, each objective has been broken into a set of attributes which we can observe and record from the 
literature. These attributes were developed with the input of two decision scientists and refined inductively 
during a preliminary review conducted by the first two authors (EK and SM) and reported in (Kyrimi et al. 
2020). In addition, two decision scientists experienced in developing BNs and who were not involved in the 
preliminary study were asked to further refine the selected attributes.   
The proposed framework was also used to ensure a consistent review of the literature. To further empower a 
consistent review process, a set of tools that included a systematically designed online literature review 
questionnaire and a manual for researchers on how to interpret and respond to the review questions was 
distributed. The manual provided a detailed definition for each attribute and a clear explanation of how to 
identify that attribute in the literature being reviewed. Additional training sessions were conducted during 
which 3 papers were reviewed by our reviewers, followed by a thorough discussion on the given answers and 
how they were derived. Each paper in this review was examined by two reviewers who entered their responses 
into the secure online survey tool. In cases where responses differed, two senior reviewers (EK and SM) 
reviewed the paper collaboratively and resolved the conflict by consensus. 
5 Results 
5.1 Literature search and collection results 
Our initial search identified a collection of 3810 papers for screening. After applying the screening process 
described in Section 4.1, 462 papers remained for eligibility assessment. As the objective of this review was 
to investigate: (1) the targeted decision support, (2) the BN modeling process, and (3) the BN usefulness in 
healthcare, we excluded as ineligible papers whose focus was on any of the following: 
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1. Bayesian statistics, as opposed to Bayesian networks 
2. Simple naive Bayesian or neural networks 
3. Network meta-analysis 
4. The predictive performance of multiple machine learning algorithms 
Those works that did not focus on a medical application were also not eligible for inclusion. 123 papers met 
the selection and eligibility criteria and remained for inclusion in this review. The results of the literature 
selection process are presented in diagrammatic form in Figure 3. The full list of these 123 papers is provided 
in https://pambayesian.org/interim-data/ 
	
Figure 3: Scoping review literature selection.  
5.2 Literature search and collection results 
This section presents results from analysis of included literature with respect to the elements identified for 
each of the first three objectives of the review as illustrated in Figure 2. 
5.2.1 Decision support 
As shown in Figure 4, the first objective of this review was to identify the aim of medical BN models 
described in the literature. This section applies the methodology described in Section 4.2 and presents the 
results of that investigation. 
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Figure 4: Concept map for the first objective of the scoping review.  
In the vast majority of papers observational reasoning was performed, for example: Gianaroli et al. (2013), 
Qian, Wang, and Jiang (2014), Wang et al. (2015), Agarwal, Verma, and Mallik (2016), Ong et al. (2017) 
and Dranca et al. (2018). Figure 5 shows that there is a range of decisions for which observational reasoning 
may be applied. Diagnosis of a medical condition given a set of known risk factors and observed signs and 
symptoms is the most frequent, as may be seen in examples such as the works of Karaca et al. (2013), Qian, 
Wang and Jiang (2014), Khademi and Nedialkov (2015), Refai, Merouani, and Aouras (2016), Kuang et al. 
(2017), and Liu et al. (2018). For a review and detailed description of the scope of targeted medical conditions 
identified from our literature collection, we refer the reader to (McLachlan et al. 2020). Interventional 
reasoning was much less frequent and was mainly used for treatment selection, such as seen in Sesen et al. 
(2013), (2014), Liu et al. (2015), Constantinou et al. (2015), Zarikas, Papageorgiou, and Regner (2015). In 
three papers, namely, the two included works of Constantinou et al. (2015), (2016) and single work from Xu 
et al. (2018), interventional reasoning was performed for managing acceptable risk through consideration of 
a number of relevant interventions. In one paper by Neapolitan et al. (2016), interventional reasoning was 
used to predict prognosis: that is, the likelihood of treatment success. In the papers published by Hernadez-
Leal et al. (2013), Cai et al. (2015), Khademi and Nedialkov (2015), Fuster-Parra et al. (2016), Solomon et 
al. (2016) and Chao et al. (2017), interventional reasoning was mentioned as a potential future use for their 
developed BNs. While the use of the published BNs to answer counterfactual questions was discussed by 
Solomon et al. (2016) as a potential future direction, it is only in the work of Constantinuou et al. (2015) that 
the proposed BN was actually applied in a counterfactual setting. Finally, in a significant proportion of the 
literature, particularly in the works of Hernadez-Leal et al. (2013), Kim et al. (2014), Frohlich et al. (2015), 
Jin et al. (2016), Zeng, Jiang, and Neapolitan (2016), Lee and Jiang (2017) and Noyes et al. (2018), no true 
reasoning process was performed. Rather, the BN was used to learn associations or causal relationships from 
data in order to understand and provide causal attribution to a disease, which relates more to BN model 
development rather than BN model use or its potential for application in clinical practice. 
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Figure 5: Distribution of decision types and reasoning processes identified in BN literature. 
5.2.2 Modelling approach 
Figure 6 presents the concept map of elements for the second objective of the review, whose main focus is 
the investigation of the BN development process with the goal of establishing current state-of-the-art from 
the literature. This section presents the results of the survey on this objective.  
 
Figure 6: Concept map for the second objective of the scoping review.  
The results on reviewing the time dynamics of proposed medical BNs are presented in Figure 7. Most papers 
described static BNs without a time element. The type of decision support possible influences, and is 
influenced, by the temporal aspect of the medical problem. Thus, there is an interconnection between 
Objective 1 and the time dynamics of the model. Static BNs, such as those presented by Vila-Frances et al. 
(2013), Farmer (2014), Khademi and Nedialkov (2015), Agarwal et al. (2016), Kuang et al. (2017), Ong et 
al. (2017) and Moreira and Namen (2018) were mainly proposed for diagnosis of a medical condition. A 
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large number of static BNs were also applied to identify causal attributions, for example Liu et al. (2015), 
Zhang et al. (2015), Cardin et al. (2016), Soto-Ferrari, Prieto, and Munene (2017) and Gross et al. (2018). In 
other words, static BNs were used in situations where time was not a significant factor. In around 16% of the 
reviewed papers we identified BNs that implicitly captured time either through specific temporal nodes, like 
in the works of Akhtar and Utne (2014), Cai et al. (2015), Lee et al. (2016), Takenaka and Aono (2017) and 
Xu et al. (2018), or by modeling prior and/or post treatment variables such as those seen in the works of 
Constantiniou et al. (2015), (2016), Luo et al. (2017) and Sesen et al. (2013), (2014). In only 14% of the 
papers, for example the works of Sandri et al. (2014), Orphanou, Stassopoulou, and Keravnou (2016), Philipp 
et al. (2017) and Yousefi et al. (2018), temporal BNs were identified. While temporal BNs were mainly used 
in the performance of outcome prediction, a process described medically as prognosis (Exarchos et al. 2013; 
2015; Velikova et al. 2014; Orphanou, Stassopoulou, and Keravnou 2014; Orphanou et al. 2016; Yousefi et 
al. 2018), we were also able to observe that prognosis models were quite uniformly distributed across the 
entire temporal scope. Finally, for almost 10% of the literature collection, including the works of Haddad, 
Himes, and Campbell (2014), Chang et al. (2015) and Vemulapalli et al. (2016) the presence of a time 
dynamic in the problem or proposed model was not clearly described and therefore classification of this 
element was not possible. 
	
Figure 7: Distribution of decision types and time dynamics identified in BN literature. 
As shown in Figure 8a, in most of the papers, including those of Alobaidi and Mahmood (2013), 
Loghmanpour, Druzdzel, and Antaki (2014), Khademi and Nedialkov (2015), Ojeme and Mbogho (2016), 
Liu et al. (2017) and Yetton et al. (2018), the BN variables originated purely from data. However, in almost 
20% of the papers, the BN variables were obtained from knowledge elicited from medical experts or extracted 
from published scientific evidence. Further, in one-third of the knowledge-driven BNs such as those 
developed by Yet et al. (2014), Sandri et al. (2014), Kalet et al. (2015), Constantinou et al. (2016) and Philipp 
et al. (2017), the BN variables were elicited from experts through a series of interviews. In two papers 
published by Jochems et al. (2016) and Takenaka and Aono (2017) the variable selection was based on a 
previous study, while in another published by Chang et al. (2015), an ontology was used to resolve the BN 
structure. In few BNs, the variables were elicited either from both experts and literature (Yet et al. 2013; 
2014; Bandyopadhyay et al. 2015; Farmer 2014; Velikova et al. 2014; Caillet et al. 2015; Yang et al. 2015; 
Tylman et al. 2016; Magrini, Luciani, and Stefanini 2018) or from a combination of clinical expertise and 
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templates, such as ontologies and fragments (Constantinou et al. 2015; Refai et al. 2016; Marvasti, Yoruk, 
and Acar 2018). Finally, in almost 12% of the papers the BN variables originated from both data and 
knowledge, such as the works of Sesen et al. (2013), (2014), Frohlich et al. (2015), Neapolitan et al. (2016), 
Cypko et al. (2017), and Sa-ngamvang et al. (2018). 
Referring now to the arcs that connect the variables in the BN, the majority were learned only from data 
using different constraint or score based learning algorithms (Figure 8b), such as those found in the works of 
Hernandez-Leal et al. (2013), Karaca et al. (2013), Liu et al. (2015), Vemulapalli et al. (2016), Jiao et al. 
(2017) and Aushev et al. (2018). In 25% of the published BNs, the arcs were elicited from knowledge, where 
clinical expertise was the main source, as in the work of Sandri et al. (2014), Zarikas et al. (2015), 
Constantinou et al. (2016), Phillip et al. (2017). In a paper published by Zarringhalam et al. (2014) the arcs 
between variables were elicited from literature, while in a smaller number of papers rules, described as arising 
from predefined templates or ontologies, were used (Vila-Francés et al. 2013; Akhtar and Utne 2014; Chang 
et al. 2015; Agarwal et al. 2016; Gámez-Pozo et al. 2017). In addition, a combination of knowledge and rules, 
specified as templates and idioms (Neil, Fenton, and Nielsen 2000) was also used to elicit the BN arcs, such 
as in Yet et al. (2013), (2014), Velikova et al. (2014), Orphanou et al. (2016), Magrini et al. (2018). 
Furthermore, mixed approaches, where structure learning algorithms alongside causal constraints provided 
by experts, literature or causal rules, were used, for example in the works of Fuster-Parra et al. (2016), Chao 
et al. (2017), Sesen et al. (2014), Shen et al. (2018) and Xu et al. (2018). 
 
 
 
 
 
 
 
 
 
 
a) 	
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Figure 8: Origin of BN inputs; a) variables, b) arcs, c) parameters. 
As shown in Figure 8c, in the vast majority of papers, including those Gianaroli et al. (2013), Akhtar and 
Utne (2014), Khademi and Nedialkov (2015), Lee et al. (2016), Nandra et al. (2017) and Aushev et al. (2018), 
the BN parameters were learned purely from data. In only 5% of the papers the parameters were learned 
from knowledge with clinical expertise being the main source of it (Agarwal et al. 2016; Lou et al. 2017; 
Philipp et al. 2017). In two papers the BN parameters were elicited only from literature (Moreira et al. 2016; 
Tylman et al. 2016), while in another one the parameters were elicited from a combination of experts, 
literature and the use of mathematical functions (Velikova et al. 2014). In 11% of the published BNs their 
parameters were based on both data and knowledge, like in the works of Yet et al. (2014), Constantinou et 
al. (2015), (2016), Liu et al. (2017), and Magrini et al. (2018). 
Each paper was evaluated regarding how detailed the overall BN development process was. In 48% of the 
studied papers, for example Berchialla et al. (2014), Yang et al. (2015), Zeng et al. (2016), Alobaidi and 
Mahmood (2013) and Xu et al. (2018), the steps followed for developing and validating the BN were either 
completely omitted or could only be implied. In less than a quarter of the literature, the overall development 
process was either described in detail in the text, for instance in the works of Kalet et al. (2015) and Magrini 
et al. (2018), or visually illustrated as seen in the works of Yet et al. (2014), Akhtar and Utne (2014), 
Constantinou et al. (2015), Chao et al. (2017) and Park, Chang, and Nam (2018). Generally, in this study we 
found that papers written by decision scientists and clinicians collaboratively tended to be more repeatable 
than those papers written by either group alone.  
Apart from analyzing the overall development process, we further investigated whether the BN structure and 
parameter learning, or elicitation process was detailed enough to be considered as repeatable. As shown in 
the inner pie of the doughnut graph in Figure 9a, from the papers where the origin of the BN structure was 
specified, 65% were learned from data (either completely or partially) and 35% from knowledge (either 
completely or partially). The outer layer of Figure 9a identifies that in situations where the BN structure was 
learned from data, papers were almost uniformly distributed between those with negligible, insufficient, and 
sufficient detail regarding the structured learning process. In 24% of the papers, such as those written by  
Lappenschaar et al. (2013), Berchialla et al. (2014), Yang et al. (2015), Turhan, Bostanci, and Bozkurt (2016), 
Bukhanov et al. (2017) and Seixas et al. (2018), the authors gave only simple statements such as the BN 
structure was learned from data or the structure was learned using supervised (or unsupervised) learning 
algorithms, which are incomplete descriptions that do not allow the reader to fully understand the process 
used. In 23% of the data-driven BNs greater detail, such as the name of the learning algorithm used, was 
provided. Examples include: Exarchos et al. (2013), Cai et al. (2015), Zador, Sperrin, and King (2016), Jiao 
et al. (2017) and Liu et al. (2018). Finally, in 18% of the data-driven BNs a detailed description of the 
structured learning approach was provided, such as those found in Ji and Wang (2014),  Fuster-Parra et al. 
(2016), Mcheick et al. (2017) and Hu and Kerschberg (2018). Conversely, in the vast majority of papers 
where the BN structure was elicited from knowledge no description of the elicitation process was given, as 
in the works of  Bandyopadyay et al. (2015), Wang et al. (2015), Orphanou et al. (2016), Cypko et al. (2017), 
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Xu et al. (2018). Statements such as the model was constructed by two experts or structure was based on 
expert domain knowledge or the structure was determined by combining known relationships from the 
medical literature with input from our clinical collaborations provided the totality of methodological 
description. In situations where the BN structure was derived from ontologies, the process was usually 
described with sufficient detail (Akhtar and Utne 2014), (Chang et al. 2015), (Agarwal et al. 2016). In two 
papers published by Kalet et al. (2015) and Seixas et al. (2014) a detailed description of the elicitation process 
was provided. Regardless of the origin of the BN structure, a complete BN was provided in 53% of the papers, 
while a description of the variables included in the BN and their states were provided in only 28% of the 
studied papers, such as  Sesen et al. (2013), Qian et al. (2014), Constantinou et al. (2015), Orphanou et al. 
(2016), Nandra et al. (2017), Moreira and Namen (2018).  
As shown in the inner pie of the doughnut graph in Figure 9b, from the papers where the origin of the BN 
parameters was specified, 85% were learned from data (either completely or partially) and 15% from 
knowledge (either completely or partially). In 58% of the papers, where BN parameters were learned from 
data, no description of the learning process was provided, as in Hernadez-Leal et al. (2013), Gianaroli et al. 
(2013), Liu et al. (2015), Frohlich et al. (2015), Refai et al. (2016), Ong et al. (2017), Park et al. (2018). In 
such cases, the authors simply mention that the BN parameters were learned from data without any further 
information. Only three papers provided a detailed description of the parameter learning process (Ducher et 
al. 2013; Van der Heijden, Velikova, and Lucas 2014; Constantinou,et al. 2015). Regarding the knowledge 
driven BN parameters, in 10% of the papers, the parameter elicitation process was not described, for example 
Tylman et al. (2016) and Lou et al. (2017). Finally, in only three papers the parameter elicitation process was 
described in depth (Yet et al. 2013; 2014; Constantinou et al. 2015). Regardless of the origin of the BN 
parameters, marginal probabilities or complete NPTs were rarely provided. More specifically, in 27% of the 
papers some parameters were presented, while a full list of parameters was available in only 7 papers (Karaca 
et al. 2013; Qian et al. 2014; Jochems et al. 2016; Lee et al. 2016; Neapolitan et al. 2016; Dranca et al. 2018; 
Merli et al. 2016).   
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Figure 9: Detailed BN development process; a) BN structure learning and elicitation process, b) BN parameter 
learning and elicitation process.   
The last modelling approach element studied in this part of the review was to identify the BN software used 
by authors. We see from Figure 10 that in 35% of the papers either the software used was not specified or  
the authors implemented their own ad-hoc software (Hernandez-Leal et al. 2013; Exarchos et al. 2013; 
Haddad et al. 2014; Li et al. 2015; Moreira et al. 2016; Ong et al. 2017; Shen et al. 2018). The two software 
tools most often used were GeNIe™ (Jochems et al. 2016; Cypko et al. 2017; Magrini et al. 2018) and R™ 
(Zador et al. 2016; McNally et al. 2017; Noyes et al. 2018). 
	
Figure 10: Software used in BN Development. 
5.2.3 Model usefulness 
Figure 11 presents the concept map of elements for the third objective of the scoping review, whose focus is 
to identify the BN usefulness in clinical practice. This section presents the results of the survey on this 
objective. 
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Figure 11: Concept map for the third objective of the scoping review. 
Figure 12 presents the frequency of elements related to BN usefulness in healthcare. Most papers clearly 
described some clinical benefit for their medical BN, as in Berchialla et al. (2014), Yet et al. (2013), Velikova 
et al. (2014), Li et al. (2015), Agarwal et al. (2016), Nandra et al. (2017), Yousefi et al. (2018). Many papers 
also provided BNs where an accepted approach was used to evaluate and report the accuracy of models and 
their predictions, like in the works of Velikova et al. (2013), Sandri et al. (2014), Yin et al. (2015), Zador et 
al. (2016), Kuang et al. (2017), Shen et al. (2018). However, generalizability could be identified in only 5% 
of papers, for example: Li et al. (2015), Orphanou et al. (2016), Soto-Ferrari et al. (2017) and Luo et al. 
(2018). From the published BNs, only 34% appeared to be credible per the definition in Table 1. Two thirds 
of these were knowledge-driven, a strong indicator that the BN structure was sensible, e.g.: Yet et al. (2014), 
Zarikas et al. (2015), Constantinou et al. (2016), Gamez-Pozo et al. (2017) and Magrini et al. (2018). From 
the credible BNs only 8 were learned completely from data, including those of: Lappenschaar et al. (2013), 
van der Heijden et al. (2014), Jin et al. (2016), Mcheick et al. (2017) and Ong et al. (2017). In the majority 
of data-driven BN structures, the model’s credibility was difficult to be identified. Two of the rarest 
characteristics to identify were the model’s usability and impact. To find usability we sought whether the 
authors proposed or demonstrated an interface, as well as whether they had also validated that interface using 
experts. In less than 1% of the papers an interface was proposed. Examples can be found in Vila-Frances et 
al. (2013), Liu et al. (2015), Chang et al. (2015), Agarwal et al. (2016), Mcheick et al. (2017), Park et al. 
(2018). From the papers, where an interface was presented, only one described evaluation of the proposed 
interface (Chang et al. 2015). Two types of impact were identified: (1) potential impact, indicating that a 
small study on whether the developed BN can impact clinical decision making was performed; and (2) actual 
impact, indicating that a trial had been conducted to evaluate whether the BN could be applied in a longer-
term implementation. In only three papers the potential impact of the developed BN was investigated 
(Constantinou et al.2015; Chao et al. 2017; Mcheick et al. 2017). The actual impact of the BN was not 
identified in any paper in this survey. Finally, there was nothing to suggest that any of the BN models in this 
review were in current clinical use. 
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Figure 12: Frequency of the properties related to the BN usefulness in healthcare. 
6 Major Findings 
During the review a taxonomy was deductively resolved that classifies concepts related to each of the three 
objectives. Various approaches exist for resolving knowledge and defining the taxonomy, but at their core 
taxonomies are systematic classifications within a domain of interest that typically present as hierarchical, 
multidimensional arrangements of linked categories of concepts (Gilchrist 2003; Kakabadse, Kakabadse, and 
Kouzmin 2003; Bowman and Nichols 2002). It is not unusual to observe taxonomies represented in almost 
every conceivable shape, including: linear (Triplett 2018), circular (Atkinson 2015), flow diagrams (Van Der 
Maaten, Postma, and Van Den Herik 2009) and so on (Jordan 2007). While most taxonomies are observed 
to be unidirectional and therefore arranged similar to a concept hierarchy, from most general to most specific, 
our review resolved a bi-directional taxonomy for each of the three objectives presented in this work. Each 
taxonomy also provides secondary information in that the weight of the connecting line, as described in 
Figure 16, represents the frequency of papers (as an overall percentage of papers in the review) whose work 
is represented by the relationship between the two identified nodes.  
	
Figure 16: Line weight and percentage of papers. 
6.1 Decision support 
The first taxonomy presented in Figure 17 contextualizes the relationship between the problem to be solved 
and the type of decision support being employed. Three reasoning types were identified from the literature. 
As can be seen by the indicated line weight, the vast majority of developed BNs engaged in a process of 
observational reasoning, leaving interventional and counterfactual reasoning significantly underexplored. 
Further, four clinical decision types and four decision contexts were identified. Diagnosis was the most 
frequent clinical decision, for which only reasoning from evidence was required. The most frequent decisions 
related to interventional reasoning were treatment recommendations. From the decision contexts, learning 
causal attributes was more frequently observed. A summary of the major findings related to the first objective 
of this scoping review is presented in Textbox 1. A further detailed discussion on these findings can be found 
in Section 7.  
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Figure 17: Taxonomy of the first objective of the scoping review. 
Textbox 1: Major findings related to the first objective - decision support. 
1. Majority of developed BNs support reasoning from evidence 
2. Few BNs on interventional reasoning 
3. Only one BN on counterfactual reasoning 
4. The two most common aims of the published BNs were to help diagnosis and learn causal attributes 
from data		
 
6.2 Modeling approach 
The second taxonomy shown in Figure 18 focuses on the interplay between model development and the 
developers engaged to the task. Three types of time dynamics were identified with more than half of the 
published BNs identified as static: used in circumstances where no time element was essential to the model. 
Three elements, variables, arcs and parameters, are necessary for representing the developed BN. As can be 
seen in the taxonomy, data-driven approaches were more common than the knowledge-driven methods that 
rely on experts, literature or ontologies. The approach of learning, or eliciting, each element was 
characterized as being bespoke to the published case, or generic to the degree of being potentially repeatable. 
On the developer side our review identified two primary developer actors: decision scientists, such as 
computer scientists and statisticians; and clinicians. We were able to classify three potential development 
approaches: method-, problem- and hybrid- driven. It was apparent from a thorough reading of the literature 
that hybrid-driven papers provided a more generic development approach. A summary of the major findings 
related to the second objective of this scoping review, is presented in Textbox 2. A further detailed discussion 
on these findings can be found in Section 7.    
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Figure 18: Taxonomy of the second objective of the scoping review. 
Textbox 2: Major findings related to the second objective - modeling approach. 
1. 57% of the published BNs were static models with no time element 
2. A prevalence of data-driven over knowledge-driven models 
3. The methodologies employed for learning data-driven BNs was described in greater detail than that 
for eliciting knowledge-driven BNs  
4. The process of eliciting the BN structure and/or parameters from experts was rarely described in the 
literature 
5. Experts were a major source of knowledge for eliciting the BN structure and/or parameters  
6. The literature lacked a well described overall development process 
7. Hybrid-driven papers were found to be more generic in approach and application 
8. The complete BN structure was not provided in 47% of the papers reviewed and in those where the 
BN structure was available, a detailed description of the variables was rarely given 
9. NPTs were not provided in 73% of papers in this review 
6.3 Model usefulness 
Figure 19 presents the third and final taxonomy, which classifies the BN’s potential or claimed usefulness 
and connects this with elements that can measure potential for successful engagement of BNs in clinical 
practice. Six main elements were identified for the potentially useful BN that are grouped into three main 
categories. These evaluate the BN’s: applicability, validity and adoptability. As can be observed from the 
thickness of the connecting lines, benefit, accuracy, and credibility were the most observed elements in this 
review. It was interesting to note that the BN model’s adoptability was identified as the most neglected 
category, as this was also reflective of the lack of works claiming to present a model that had been adopted 
in some way into clinical practice. A summary of the major findings related to the third objective of this 
scoping review, is presented in Textbox 3. A further detailed discussion on these findings can be found in 
Section 7.  
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Figure 19: Taxonomy of the third objective of the scoping review. 
Textbox 3: Major findings related to the third objective - model usefulness. 
1. The elements most frequently identified in the literature were benefit, credibility and accuracy 
2. Knowledge-driven BNs appeared more credible on review than data-driven BNs 
3. A model’s generalizability and usability were rarely specified 
4. The clinical impact of developed BNs was the most underexplored element in the literature  
5. A gap exists between developing an accurate model and having a useful model that can be adopted in 
healthcare 
7 Major Findings 
This scoping review intended to examine and evaluate the: (1) targeted decision support; (2) modelling 
approach; and (3) usefulness in practice for BNs in healthcare. We found that the literature on BNs in 
healthcare could be broadly grouped into: (1) method-driven, (2) problem-driven, and (3) hybrid-driven 
papers. On one hand, method driven papers were seen to be primarily written by decision scientists and their 
focus was on a specific aspect of the modelling methodology. Hence, the BN development and validation are 
usually described in greater detail than the clinical benefit and potential impact in practice, which appear to 
have been neglected by most researchers. On the other hand, problem driven papers were mainly written by 
clinicians and their focus is on the medical application. In this type of papers, the clinical benefit and medical 
background are usually described in detail, while the BN development is usually only vaguely explained. 
Hybrid papers result from a collaboration between decision scientists and clinicians and the content of their 
works tended to be more equally divided between the clinical and modelling aspects of the BN. Hybrid papers 
were found to be the most complete of the three types of papers. The remainder of this section provides a 
more thorough analysis of the review findings associated with each objective, while also discussing the 
strengths and weaknesses of the review process undertaken. 
7.1 Discussion of findings 
Decision Support: In many of the published BNs no real reasoning was performed as the aim of most works 
was to identify, or learn, relationships or causal attributes from the data. In BNs where reasoning was 
undertaken, the vast majority sought to help clinical decision-making, such as for diagnosis or prognosis. In 
these instances, reasoning from evidence was most often used. Interventional and more especially 
counterfactual reasoning were significantly underexplored, indicating that BNs are not being used to their 
full potential. Despite the benefit of counterfactual reasoning in answering important questions regularly 
asked by clinicians, such as Would the patient have survived, if we had operated him sooner?, counterfactual 
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analysis is still considered by many as a contentious research approach. There is a debate as to whether 
counterfactual reasoning has scientific validity, or whether it is merely a metaphysical process with no 
observable or testable consequences (Dawid 2000). This might explain the extremely small number of BNs 
in which a counterfactual reasoning approach was undertaken. While most of the published BNs are static 
models with no or implicit time element, we know that time plays a crucial role in clinical decision-making 
and that BNs can model these dynamic processes yet temporal BNs remain less popular. This might be 
explained by the difficulty of modelling temporal BNs, as they are structurally more complex and require 
more computational power to perform inference. It may also be due to the perceived unavailability or 
incompleteness of temporal datasets from which to draw knowledge necessary to making those inferences. 
Modeling Approach: In 48% of the papers, description of the overall BN development process was either 
absent or could only be inferred from the description of the case study. In only a small number of papers was 
the BN development description detailed enough to reach a level of being potentially repeatable. The number 
of BNs where the structure was learned only from data was twice that of BN structures elicited from 
knowledge. This may be because structured learning is less time-consuming and is usually based on well-
known learning algorithms, which makes the process more repeatable. The vast number of data-driven BNs 
in medical applications came as a surprise if we consider the fact that they are based solely on medical data, 
which are not always good enough or complete enough to be used as the only source for learning a causal 
structure (Hernandez-Leal et al. 2013; Magrini et al. 2018). Many times, the quality of medical data for 
research purposes was described as poor, and poor data therefore means meaningless data-driven BN 
structures (Constantinou et al. 2016). Moreover, even if the available data includes information on all 
necessary variables, there are typically far too many variables and far too few samples in the dataset to 
achieve any sensible structural learning outcome (Constantinou et al. 2016). When the BN structure is learned 
from knowledge, the structure is more sensible as it can more correctly represent the true causal mechanisms. 
However, the elicitation process is time-consuming and may be prone to errors, especially when it is based 
only on the input of a single domain expert (Bielza and Larranaga 2014; Constantinou et al. 2015). 
Additionally, the way a BN structure was elicited from knowledge was rarely described in the literature, 
making the process ad hoc and less able to be standardized. In other words, elicitation process descriptions 
were found to be ambiguous as insufficient detail was provided for the reader to understand where the BN 
structure came from. This makes it near impossible to duplicate the authors’ process and duplicate their 
findings. Regardless of the origin of the BN structure, in almost half of the papers the complete BN structure 
was not provided. This also makes the process of verifying or using the structure impossible. In 85% of the 
papers the BN parameters were learned from data (either completely or partially). The process, either data or 
knowledge driven, was usually not described in detail. Parameter learning from data is more straightforward, 
while eliciting parameters from knowledge is less intuitive and results in subjective parameters, therefore a 
detailed description of the parameter elicitation should be a requirement of any BN in healthcare publication. 
Regardless of the origin of the parameters, the NPTs, which could be used as an important source of 
knowledge for other researchers, were rarely provided in the literature. Finally, in spite of the advantages of 
mixed approaches for developing BN structures and parameters using both data and knowledge, only a small 
number of BNs developed by mixed approaches were identified in the literature. 
Model Usefulness: While the majority of published BNs addressed a clinical problem of significant 
importance and were shown to have an acceptable predictive performance, there appeared a significant gap 
between having an accurate model and demonstrating a clinically useful model capable of delivering an 
actual impact on healthcare decision making. A description of the model’s credibility was frequently 
observed in the literature. Particularly, papers with knowledge-driven BNs provided more convincing 
evidence of model credibility than those with data-driven BNs. Important elements for having a useful model, 
such as generalizability, usability and impact were either vague or overlooked in the literature. 
Generalizability is important for achieving BN adoption in healthcare as a model could not be used widely 
in practice if it has not first been proven to work on alternative populations and therefore applied to the 
broader health consumer population. Another important aspect considered was whether user-friendly 
interface and an impact analysis to study the benefit of the model and its integration into the existing 
workflow had been performed. In this review, no single BN adhered to all of the prescribed elements 
	 22	
necessary for having a useful model. In addition, there was no evidence in this review to suggest that any of 
the BN models were in current clinical use. This does not categorically mean there are no BNs in clinical 
practice, only that in this review we did not find a publication describing its BN as currently engaged in 
clinical practice. 
7.2 Strengths and limitations 
The first strength of this review is that this is the largest review of BNs in healthcare targeting three 
objectives; (1) decision support, (2) development, and (3) usefulness, which, when combined, provide a 
comprehensive assessment of the domain. Several attributes related to each objective were identified based 
on a preliminary short review of the literature (Kyrimi et al. 2020) followed by a comprehensive review 
process conducted by a panel of experts. The second strength is that in order to ensure a consistent review 
process, a set of tools were developed that include a detailed framework capturing all the necessary attributes, 
a systematically designed online literature review questionnaire and a manual to guide the respondents on 
completing the questionnaire. In the manual a detailed description on what each attribute means and a clear 
explanation on how to identify each attribute in a published paper were provided. An additional training event 
for the reviewers was conducted to make sure that all the participants were comfortable and had a robust 
understanding of the review process. In addition, to further guarantee that all the attributes were identified 
correctly, each paper was reviewed by two reviewers; one experienced and one junior. In cases of 
disagreement on an attribute of the review, two senior reviewers performed a final review of the paper 
collaboratively so that consensus could be achieved. In this review 123 papers were identified following the 
screening process and reviewed in order to address a significant gap in the literature. However, this review 
has the following limitations: 
1. Possible missing relevant papers: Even if this is a representative sample of papers published in both 
medical and AI journals and conference proceedings, it may not reflect the entire range of the literature 
regarding BNs in healthcare. We looked for keywords such as Bayesian Networks, probabilistic 
graphical models, medical, clinical to appear in the abstract of each paper. It is possible that a small 
number of relevant papers were not included because they did not use the selected keywords in their 
abstract. This is especially true in cases where the actual name of the medical condition is described 
without mentioning the words medical or clinical. However, we believe that the large number of selected 
papers was sufficient for drawing conclusions.  
2. Limited time period: Because of the plethora of published papers and the time needed for review and 
data extraction we limited the study to the seven-year period 2012-2018. Although this a safe number of 
years to be able to draw conclusions, papers published before 2012 were not reviewed. As the review 
began in early 2019, so we decided not to include papers published in 2019, as we believe that adding a 
year will have no significant contribution to our findings.  
3. Subjectivity: Despite the detailed framework, the well-designed online survey and the guiding manual a 
few of the attributes were subjective and difficult to be identified. For instance, to capture how generic 
was the overall development process as well as the structure and parameter learning or elicitation 
process, a subjective 5-scale answer was provided with the labels: None, Implied, Some evidence of 
method, High level of description, and Repeatable. For some papers choosing the appropriate state was 
difficult and it was based on reviewer judgement. For evaluating the clinical usefulness of the BN in 
practice a set of elements previously described in the literature were examined. Some of these elements 
were again subjective and many times not clearly stated in the papers. However, to increase the 
correctness of our findings, each paper was read by two reviewers and a consensus was achieved in case 
of a disagreement.  
4. Possible missing evidence of adoption: One of our key findings was the total absence of clinical adoption 
of any BN in the literature reviewed. However, it is possible that evidence for subsequent translation and 
adoption of BNs into the real world may well appear in other places, such company reports, media, 
general commentaries and not necessarily in journal articles. For instance, based on limited marketing 
materials, there are indications that Babylon is using BNs in their non-public research and application 
development (Armstrong 2018), including what is claimed as the largest BN in the world (MMC 
Ventures 2017). As a result, BNs that have been actually used in practice might have been missed. For 
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that reason we tried to infer the adoption of the published BNs in practice either from the overall 
impression of the paper or based on whether the BN follows all the rules necessary for having a useful 
model, as a model cannot be applied in practice if it has not been proven to be useful first. 
8 Recommendations for researchers 
In this section, specific recommendations for improving the reproducibility of the modelling approach 
described in published papers as well as the usefulness of the BNs in practice are presented.  
1. The clinical benefit of the BN should be explained in depth: As discussed in the third objective of this 
scoping review, the clinical benefit of a BN was usually explained in the published papers. However, 
there were many cases where the benefit was not provided, and therefore the aim of the BN was difficult 
to understand. The clinical benefit should be stated at the beginning of each paper, preferably supported 
with relevant literature and statistics that justify the need for a BN capable of performing better than the 
current practice standard. The effort of developing a BN to be used as a CDSS should be based on the 
need to address an important clinical problem with a significant potential benefit. Making the extra effort 
of thinking and describing the benefit from the beginning can help readers better understand the model’s 
aim, and researchers better understand the future impact a model may have. One example of properly 
representing the benefit of the BN can be seen in the introduction of the work by Ducher et al. (2015).  
2. The structure and the variables of the BN should be provided: The second objective of this review 
identified that, in most papers, neither the BN structure nor the variables were clearly described. This 
makes it difficult to review the BN logic, and hides important knowledge that could potentially be used 
in other studies. As a result, the complete BN structure should be provided in a paper, and further, the 
variables of the BN should be fully described. Tables that include the full variable name, a description 
of the variable and its possible states are extremely useful and can be a significant source of knowledge 
that improves readers comprehension of the proposed model. An example of how variables should be 
described in this manner can be found in the papers published by Velikova et al. (2014) and Constantinou 
et al. (2015).   
3. The parameters of the BN should be provided: Also, from the second objective of this review we 
identified that in most papers the BN parameters were not disclosed. Failure to disclose the parameters 
completely inhibits reproducibility of the claimed results. Additionally, complete NPTs can be a valuable 
source of knowledge for similar studies. To resolve this issue the marginal prior probabilities and 
complete NPTs should always be made available to the reader. An illustrative example on how NPTs 
should be presented can be found in the work of Jochems et al. (2016).    
4. The BN development process should be explained in detail to the point of being repeatable: We identified 
in the second objective of this review that the vast majority of published papers failed to fully describe 
the BN development process. Absence of a clear development process makes the research difficult to 
follow and impossible to duplicate. For that reason, the overall methodology should be described in a 
generic way to improve the readers comprehension of the approach used, and their ability to replicate 
the methodology used. A diagrammatic illustration of the overall methodology can be very informative, 
such as the one presented in Yet et al. (2014). 
5. When the BN structure is elicited from knowledge, the elicitation process followed should be described 
in detail to the point of being repeatable: While reviewing the modelling approach used, we observed 
that in cases where the BN structure was elicited from knowledge the process was rarely described. To 
simply say that the BN structure was elicited from experts or literature is not a sufficient description of 
methodology. The process of extracting variables, as well as the choice of arcs to be used, should be 
described clearly and open to critique by the reader. An example of a clear and concise description can 
be found in the works of Akhtar et al. (2014) and Seixas et al. (2014).      
6. When the BN parameters are elicited from knowledge, the elicitation process followed should be 
described in detail to the point of being repeatable: Another finding from the second objective of this 
review was that in many papers where the BN parameters were elicited from knowledge, the process 
was not described in any detail. As with the previous items discussed above, this limits the reader’s 
ability to understand, critique and replicate the modelling process. Consequently, the process for eliciting 
the parameters from knowledge should be clearly described both for methodological review, and for 
repeatability. In cases where the parameters are extracted from experts it is necessary to explain not only 
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how the parameters were elicited, for instance using graphs or anchors, but also the number of experts 
involved, time and resources consumed by the process, how the different answers among the experts 
have been considered, the certainty of the elicited subjective parameters and the benefits and limitations 
of the chosen process. Similarly, when the parameters are elicited from literature a list of the publications 
that were used should be provided, the process of selecting the necessary parameters should be explained, 
and the degree of trust for the elicited parameters. An example of a well described parameter elicitation 
process can be found in Yet et al. (2013) and Constantinou et al. (2015). 
7. When the BN structure and parameters are learned from data, the learning algorithm as well as the 
dataset used, and the way missing data was treated should be provided: We identified that insufficient 
information was usually provided for the characteristics and limitations of the data that was used to 
develop data-driven BNs. This creates significant gaps in the reader’s understanding of the modelling 
process. When learning the BN structure from data, the dataset used should be described, including 
presentation of elements such as the dataset origin, size and limitations, as in Lee et al. (2017) and Zador 
et al. (2016). In addition, the learning algorithm used should be described in detail, such as in the works 
of Lee et al. (2017) and Luo et al. (2017). A significant element that should never be overlooked is how 
missing data were identified and classified, for example: not missing at random or missing completely 
at random, and so on. How this missing data was treated, i.e. whether missing values were computed or 
ignored, should also be described. A clear description of the learning process makes it easier for readers 
to follow and potentially replicate the process. A good example of a description of data pre-processing 
and how to handle missing data can be found in the paper published by Sesen et al. (2013). 
8. The credibility of a data-driven BN structure should be explained: From the third objective of this review 
we learned that the credibility of data-driven BNs was difficult to assess as it was usually underexplored 
by authors. When the BN structure is learned from data, it represents the relationships that are available 
in the dataset, which are not always in agreement with the true causal mechanisms of a given disease. 
For that reason, a justification of the model’s credibility is needed to ensure that the BN has a clear logic 
and evaluates the answer it was intended to compute. Representing true causal/ influential relationships 
is particularly important when the BN is intended for interventional or counterfactual reasoning. An 
example of credible data-driven BN structures can be found in the works of Chao et al. (2017) and 
Kaewprag et al. (2017).  
9. A validation of the model’s accuracy should be provided: As observed in the third objective of this 
review, most authors provided some claim of their model’s accuracy. However, their approach to 
assessing and validating accuracy was not always described with sufficient clarity to be easily understood 
and evaluated by the reader. In this review we found several ways to validate a BN. A simple approach 
for evaluating the model’s reasoning was through the use of specific cases or scenarios. Although useful, 
this is not sufficient to fully validate a model’s accuracy. The minimum validation process needed is 
internal validation, where the predictive performance of the model is assessed using resampling 
techniques such as bootstrapping or cross-validation. All steps followed in validation of the BN should 
be explained in sufficient detail to enable repeatability. In cases where low accuracy is observed, 
justification and potential corrections should be offered. In cases where internal validation has not been 
performed, this should be openly disclosed and suggested as future work, thus indicating the need for a 
validation study. A well-described validation and review process can be found in Yet et al. (2014). 
10. An external validation to evaluate the model’s generalizability should be considered: An important 
finding of the third objective of this review was a lack of generalizability for most of the described 
models. An accurate model may not be useful in clinical practice if it is not proven to work consistently 
on different populations. Thus, an external validation is necessary for validating the model’s 
performance on different datasets. Providing an external validation significantly strengthens the 
performance and utility of a BN. In cases where an external validation has not been performed due to 
data or time restrictions, it should be openly disclosed and suggested as future work as we see in the 
work of Park et al. (2018). An example of external validation can be found in the paper published by 
Luo et al. (2018).   
11. The actual use of the model in practice and its impact on healthcare should be considered: The third 
objective of our review identified that impact analysis was usually neglected, especially in research 
papers where the sole focus was on development of the BN. However, in order to bridge the gap between 
having accurate models and delivering impact in practice, more focus should be given to identifying 
issues and approaches to help clinicians adopt the decision support model. In cases where a small pilot 
study to investigate the potential impact of the models, such as in the work of Mcheick et al. (2017), or 
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a properly randomized control trial have not been performed, this should also be openly disclosed and 
identified as potential future work. Acknowledging the need for an impact study and how the model 
could be applied in practice to help clinical decision making provides the reader with a clear 
understanding of the intended use and the potential benefits that may result from use of the proposed 
model. A representative example acknowledging an impact analysis as a crucial future step is available 
in Velikova et al. (2014). 
9 Future Directions 
This scoping review revealed numerous research areas that have been neglected, and that should receive 
further attention in the future. The following are some of the key future research areas that emerge from this 
study:  
1. Multi-disciplinary expert team involvement in BN development: When developing medical BNs intended 
for use as CDSS there is a need for collaboration between clinicians and decision scientists. Clinical 
expertise is important to ensure that the clinical benefit and adoption of the model are considered, while 
decision scientists, computer scientists or statisticians are necessary to develop an accurate BN model.  
Methodologies and tools to support multidisciplinary expert involvement processes for BN development 
would be useful to resolving this need. 
2. Using BNs to answer hypothetical questions: BNs should be used to perform more than just reasoning 
from evidence. They can also be used to answer hypothetical questions. More research should focus on 
modeling and validating medical BNs for performing interventional and counterfactual reasoning.  
3. Temporal BN models: Greater effort is needed to identify better methods for developing temporal BNs 
that capture the evolving process of clinical decision making.  
4. Clinical datasets for use in harnessing ML for developing BNs: Despite supposedly being in the era of 
big data and machine learning, many papers in this review identified a lack of good quality clinical 
datasets as a barrier to developing accurate BNs. Solving the issues of data integrity, integration and 
interoperability, especially in electronic health records and routine clinical datasets, will be key to 
ensuring that health data can be used to render credible and accurate predictions and decisions for use in 
the care of individual patients and their families. 
5. Mixed methodologies for developing BNs: More work is needed to develop BNs using mixed approaches 
that are based on both data and knowledge.  
6. Tools and methods for eliciting expert knowledge for BN development: Expert elicitation remains largely 
ad hoc and research into more methodological approaches is needed in order to standardize these 
processes.  
7. Adoption of medical BNs in clinical practice: While there has been significant research interest in 
developing accurate medical BNs, their adoption in clinical practice is less obvious. More attention 
should be paid to the process of translating an accurate BN to a useful and usable CDSS that has potential 
for benefit when applied in clinical practice.    
10 Summary and Conclusions 
BNs can be successfully applied to model complex medical problems requiring reasoning under uncertainty. 
An immense interest is demonstrated by the volume of literature proposing medical BNs and the research 
effort expended globally in developing BNs to support clinical decision making. This scoping review, 
drawing on 123 papers that propose BNs in healthcare, evaluated the decision support, development and 
usefulness of BN models proposed for use in clinical practice. We found that the majority of published BNs 
focus on supporting simple decisions where reasoning from evidence is required, with authors neglecting 
more complex reasoning approaches that BNs may be applied to, and the dynamic nature of clinical decision 
making. There is a preference for data-driven BNs even though medical datasets usually lack integrity, 
presenting with poor quality and incomplete. There is also an important lack of repeatable modelling 
approaches and a significant gap between development of a claimed accurate model, and demonstration of a 
clinically useful model capable of delivering actual impact on healthcare. Consequently, we have proposed 
several future research directions and recommendations for improving reproducibility of modelling 
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approaches described in the literature, and for improving the overall usefulness of medical BNs. With these 
future directions we hope the quality and repeatability of published papers on BNs in healthcare will improve 
and that all researchers in this domain can work towards closing the chasm between research interest and 
clinical adoption. 
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